Daiwa Securities Group Inc. decreased its holdings in Catalent, Inc. (NYSE:CTLT – Free Report) by 4.0% in the third quarter, ...

Review of competitive environment, significant rivals, significant leaders and top 10 manufacturers in the CDMO sector. CDMO ...

On Wednesday, Catalent Inc (CTLT) stock saw a modest uptick, ending the day at $61 which represents a slight increase of $0.25 or 0.41% from the prior close of $60.75. The stock opened at $60.95 and ...

Charles Schwab Investment Management Inc. boosted its stake in Catalent, Inc. (NYSE:CTLT – Free Report) by 1.1% during the ...

Pharmaceutical contract manufacturing is when a company hires a third-party to produce drugs for them. The report by ...

Will the Novo-Catalent merger be challenged under the new Trump administration? A former FTC policy director thinks so.

Novo Holdings, the controlling shareholder of Novo Nordisk (NVO), is slated to received unconditional EU antitrust approval for its proposed ...

Novo Holdings is set to gain unconditional EU antitrust approval for its planned $16.5 billion takeover of U.S. contract drug ...

The European Commission is expected to give unconditional approval for the $16.5 billion purchase of Catalent (NYSE: CTLT) as ...

Catalent (NYSE:CTLT) rose 2% amid a report that the European Union's antitrust regulator will likely grant approval for its ...

Thermo Fisher has launched a suite of expanded CRO and CDMO services under its own brand, Accelerator™ Drug Development, intended to serve biotechs and pharmas.

With a market cap of $10.7 billion, Catalent, Inc. (CTLT) is a leading global provider of advanced delivery technologies and ...